PIFELTRO is a prescription HIV-1 medicine used with other antiretroviral medicines to treat human immunodeficiency virus-1 (HIV-1) infection in adults who
PIFELTRO is a prescription HIV-1 medicine used with other antiretroviral medicines to treat human immunodeficiency virus-1 (HIV-1) infection in adults who have not received HIV-1 medicines in the past, or to replace their current HIV-1 medicines for people whose healthcare provider determines that they meet certain requirements. HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
Do not take PIFELTRO if you take any of the following medicines:
Ask your doctor or pharmacist if you are not sure if your medicine is 1 that is listed above. If you have taken any of the medicines in the past 4 weeks, talk to your doctor or pharmacist before starting treatment with PIFELTRO.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
It is not known if PIFELTRO is safe and effective in children under 18 years of age.
Whether you take over-the-counter or doctor-prescribed medicines for other conditions, it is important that you talk to your doctor about all of your medicines.
PIFELTRO can be taken with a wide range of common, non–HIV-1 medicines, such as:
Do not take PIFELTRO if you take any of the following medicines:
Ask your doctor or pharmacist if you are not sure if your medicine is 1 that is listed above. If you have taken any of the medicines in the past 4 weeks, talk to your doctor or pharmacist before starting treatment with PIFELTRO.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
It is not known if PIFELTRO is safe and effective in children under 18 years of age.
PIFELTRO can cause serious side effects, including:
The most common side effects of PIFELTRO include:
These are not all the possible side effects of PIFELTRO.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Keep PIFELTRO and all medicines out of the reach of children.
Medicines are sometimes prescribed for purposes other than those listed in the Patient Information leaflet. Do not use PIFELTRO for a condition for which it was not prescribed. Do not give PIFELTRO to other people, even if they have the same symptoms that you have, it may harm them. You can ask your pharmacist or doctor for information about PIFELTRO that is written for healthcare professionals.
Active ingredient: doravirine.
Inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, hypromellose acetate succinate, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. The tablet film coating contains Hypromellose, lactose monohydrate, titanium dioxide and triacetin. The coated tablets are polished with carnauba wax.
HIV may have a negative impact on your bad cholesterol (LDL-C). In a 96-week study of adults who had never been on an HIV-1 treatment before, 320 adults received PIFELTRO as part of a treatment regimen and 311 adults received another treatment regimen.*
PIFELTRO, as part of a treatment regimen, did not increase bad cholesterol, while the other treatment regimen* did.
The benefit of these changes has not been demonstrated.
*The other treatment regimen included darunavir plus a ritonavir boost (PI + ritonavir boost), once daily.
Before treatment with PIFELTRO, tell your doctor about all of your medical conditions, including if you:
are pregnant or plan to become pregnant. It is not known if PIFELTRO can harm your unborn baby. Tell your doctor if you become pregnant during treatment with PIFELTRO.
Pregnancy Registry: There is a pregnancy registry for people who take PIFELTRO during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your doctor about how you can take part in this registry.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call FDA at 1-800-FDA-1088.
Please read the Patient Information for PIFELTROTM (doravirine) and discuss it with your doctor. The physician Prescribing Information also is available.